February 21, 2011 – TomoTherapy has shipped its 350th treatment system, which will be installed at the Hong Kong Sanatorium and Hospital (HKSH). In 2005, HKSH first treatment center in Asia to embrace TomoTherapy technology.
With the addition of the TomoHD treatment systems, HKSH will expand its treatment program to meet high patient demand and bring advanced image-guided, intensity-modulated radiation therapy (IG-IMRT) capabilities and treatment quality to a broader patient population.
“From our experience using TomoTherapy technology we have become accustomed to the integrated workflow and exceptional treatment quality that the platform affords our clinical staff and cancer patients,” said Wyman Li, manager (administration) of HKSH. “The TomoHD system installations will allow us to maximize use of this important technology within our busy clinic.”
By combining TomoHelical and TomoDirect delivery modes, the treatment system is designed to help radiation oncology teams efficiently target a broad range of cases requiring radiation therapy. Using either delivery modality, clinicians can efficiently acquire a low-dose helical CT image immediately prior to each daily treatment, to help ensure precise patient positioning based on internal anatomy. Then, with the same equipment used for imaging, the treatment team can deliver highly precise radiation to complex target volumes in a continuous, 360-degree pattern. The delivery mode facilitates a non-rotational delivery option that enables clinicians to quickly plan and deliver advanced radiation treatments with a series of linear beam paths, rather than a single helical delivery path. This improves efficiency in the treatment of more common target volumes.
“HKSH has established strict standards for all procedures in order to maintain high quality in delivering individualized treatment for each patient,” said B.Y. Lee, deputy manager (administration) of HKSH. “The availability of TomoTherapy technology has certainly helped support these efforts, but we saw a need to expand access to its benefits. The TomoHD system, with its TomoDirect delivery option, brings added versatility to a proven platform. We are confident these systems can provide state-of-the-art solutions for our high-demand environment for many years to come.”
Patient treatments are expected to commence in March. HKSH plans to install the second TomoHD treatment system later in 2011.
For more information: www.TomoTherapy.com, www.hksh.com/eng
July 11, 2024 
